comparemela.com


Focusing on small molecule drug discovery and development for cancer and autoimmune diseases BOSTON, Nov. 24, 2021 /PRNewswire/ -- Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today announced the completion of $40M Series A financing. This financing round is led by Qiming Venture Partners and participated by IDG Capital, Octagon Capital, Firstred...

Related Keywords

Guangzhou ,Guangdong ,China ,Shanghai ,United States ,Hong Kong ,Shenzhen ,Suzhou ,Jiangsu ,Boston ,Massachusetts ,Beijing ,Qiming ,Sichuan ,Chen Kan ,Shanxi , ,Shenzhen Stock Exchange ,Shanghai Stock Exchange ,Nasdaq ,Qiming Venture Partners ,Octagon Capital ,Firstred Capital ,Med Fine Capital ,Allorion Therapeutics ,San Francisco Bay ,Currently Qiming Venture Partners ,Gretai Securities Market ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.